Tumay Ak, et al. “Secukinumab After First-Line Tumor Necrosis Factor-Alpha Inhibitor Therapy in Psoriatic Arthritis: A Real-World Retrospective Cohort Study”. Archives of Rheumatology, vol. 39, no. 1, Mar. 2024, pp. 071-80, doi:10.46497/ArchRheumatol.2024.10050.